Chapters
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
Acetylcysteine tablets | On consultant advice only | ||
Amoxicillin nebulised | Hospital only | ||
Amphotericin (Fungizone) | Hospital only | ||
Azathioprine | To be administered in conjunction with prednisolone (plain tablets). Supported by ESCA. | ||
Azithromycin tablets | RICaD | ||
Carbocisteine | |||
Ceftazidime nebulised | Hospital only | ||
Cefuroxime nebulised | Hospital only | ||
Colistimethate sodium | Amber: Existing patients (initiated prior to April 2013) | ||
Colistimethate sodium (Colomycin® inhalation) | Paediatric non-CF patients | ||
Colistimethate sodium | NHS England commissioned for cystic fibrosis only. Red for new patients. | ||
Colomycin nebulised | NHS England Commissioned for Cystic Fibrosis only. Existing patients - initiated prior to April 2013 | ||
Colomycin nebulised | NHS England Commissioned for Cystic Fibrosis only, new patients | ||
Dornase alpha nebuliser solution (Pulmozyme) | |||
Dornase alpha nebuliser solution (Pulmozyme) | NHS England commissioned for cystic fibrosis only | ||
Erdosteine (Erdotin) | Hospital only | ||
Gentamicin nebulised | Hospital only | ||
Mannitol inhalation (Bronchitol®) | Hospital only | ||
Meropenem nebulised | Hospital only | ||
Methotrexate | ILD - ESCA | ||
N-Acetylcysteine nebulised | |||
Nebulised hypertonic sodium chloride (Resp-Ease) | Resp-Ease (Sodium Chloride 7% nebuliser solution) for CF patients | ||
Pirfenidone | Hospital only | ||
Prednisolone | Plain tablets | ||
Tobramycin nebulised | NHS England Commissioned for Cystic Fibrosis only. Existing patients - initiated prior to April 2013 | ||
Tobramycin nebulised | NHS England Commissioned for Cystic Fibrosis only, new patients |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.